Psoriasis is a common T-cell-mediated autoimmune infl ammatory disease. Conventional systemic therapy includes: methotrexate, cyclosporine, retinoids and psoralen ultraviolet A, which are effective, but associated with toxicity and adverse effects which may limit their long-term use. Although effective as well, data on the long-term safety of newly introduced biologic agents are still not available. Herein, we present our clinical experience with rifampicin in the treatment of psoriasis, and review of literature regarding its potential mechanisms of action.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.